STAT

FEBRUARY 5, 2024

billion deal, an acquisition that will give Novo additional sites as it builds up production of its booming obesity and diabetes drugs.     Under the deal, Novo Holdings is purchasing Catalent, a major contract development and manufacturing company with more than 50 sites globally.

Diabetes 357

Diabetes Pharmaceutical Companies Pharmaceutical Companies 357

STAT

JULY 5, 2023

WASHINGTON – Novo Nordisk spent $11 million on meals and travel for thousands of doctors last year, federal records show, as part of its push to promote Ozempic and other weight loss-inducing diabetes drugs.

Diabetes 278

Diabetes Pharmaceutical Companies Pharmaceutical Companies 278

STAT

JULY 11, 2024

Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout out as its next science chief? STAT’s West Coast biotech reporter Jonathan Wosen joins “The Readout LOUD” to discuss what’s driving workforce cuts.    Read the rest…

Pharmaceutical Companies 331

Pharmaceutical Companies Pharmaceutical Companies Diabetes 331

STAT

OCTOBER 31, 2024

… All doses of Novo Nordisk’s blockbuster diabetes and obesity treatments are listed as available  on the U.S. With all doses now listed as available, the FDA may soon pull it off the list, depending on its conversations with Novo about whether the company can sufficiently meet demand going forward. Sound familiar?

Compounding Pharmacies 278

Compounding Pharmacies Compounding Diabetes Packaging 278

STAT

JANUARY 5, 2024

… Eli Lilly started a new online service offering telehealth prescriptions and direct home delivery of its new Zepbound weight-loss drug, an unusual move into the supply chain by a pharmaceutical company with one of the hottest-selling medicines , The Wall Street Journal writes.

Diabetes 289

Diabetes Medical Records Pharmaceutical Companies Pharmaceutical Companies 289

STAT

FEBRUARY 20, 2024

Ozempic is not available for weight loss in the country, instead being reserved for the treatment of type 2 diabetes. But users on e-commerce platforms are able to buy the shots, colloquially known as “miracle drugs,” simply by declaring they have been diagnosed with diabetes — without providing proof.

Diabetes 286

Diabetes Pharmaceutical Companies Pharmaceutical Companies 286

STAT

MAY 20, 2024

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies before the panel with ambitious demands related to their pricing. Sanders (I-Vt.) is testing the limits of the powers of a Senate chairman with little hope of advancing his policy agenda legislatively.

Chemotherapy 268

Chemotherapy Diabetes Pharmaceutical Companies Pharmaceutical Companies 268

STAT

OCTOBER 24, 2023

While pharmacy benefit managers and the rebates paid to them by pharmaceutical companies will continue to drive up costs for patients in the U.S., (Sanofi and NovoNordisk will lower their prices as of January 2024; Lilly reduced it to $35 per month in March 2023.) competition on the horizon could help push down prices.

Pharmaceutical Companies 345

Pharmaceutical Companies Pharmaceutical Companies Diabetes 345

The Guardian - Pharmaceutical Industry

OCTOBER 16, 2024

Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners The pharmaceutical company behind injectable weight-loss drugs has been accused of prioritising profits over the health of people in developing countries by halting production of its insulin pens.

Diabetes 145

Diabetes Pharmaceutical Companies Pharmaceutical Companies 145

STAT

AUGUST 22, 2023

German drugmaker Boehringer Ingelheim is the latest pharmaceutical company to sue the federal government over a law that would allow Medicare to negotiate certain drug prices, Reuters reports. Continue to STAT+ to read the full story…

Vaccines 246

Vaccines Drug Pricing Diabetes Pharmaceutical Companies 246

STAT

AUGUST 16, 2023

The Chinese companies hope to compete with the Danish pharma group Novo Nordisk’s pioneering drugs in China, which has the world’s largest overweight and diabetic population. So grab that cup of stimulation — our flavor today is butter pecan, a household favorite — and get started.

Research Laboratories 246

Research Laboratories Documentation Diabetes Pharmaceutical Companies 246

STAT

SEPTEMBER 25, 2024

Senate health committee chair Bernie Sanders said major pharmacy benefit managers have agreed not to limit coverage of Novo Nordisk’s Ozempic and Wegovy if the company lowers the prices of the treatments , STAT tells us.

Diabetes 264

Diabetes Pharmaceutical Companies Pharmaceutical Companies 264

STAT

JUNE 22, 2023

Hope you have a smashing day and, of course, do stay in touch … Leaders of European pharmaceutical companies argued that a proposed overhaul of European Union policies could render the industry less competitive, the latest step in their opposition to legislation that could shorten exclusivity periods for selling drugs, STAT writes.

Diabetes 246

Diabetes Pharmaceutical Companies Pharmaceutical Companies Vaccines 246

STAT

NOVEMBER 20, 2024

The J&J cuts mainly impacted a division that sells products used in surgery, while Merck scaled back in its diabetes unit. The program has seen global pharmaceutical companies lose hospital contracts to cheaper local suppliers, essentially putting their sales teams out of work in those categories.

Hospitals 257

Hospitals Diabetes Pharmaceutical Companies Pharmaceutical Companies 257

Express Pharma

APRIL 18, 2024

Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes Biocon announced the signing of an exclusive licensing and supply agreement with Biomm S.A.,

Diabetes 105

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 105

Pharma Marketing Network

JULY 19, 2023

Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Diabetes Vaccines 98

The Guardian - Pharmaceutical Industry

JANUARY 25, 2024

Mounjaro was developed by the US pharmaceutical company Eli Lilly.

Diabetes 96

Diabetes Pharmaceutical Companies Pharmaceutical Companies 96

Express Pharma

OCTOBER 6, 2023

Biocon has signed a partnership agreement with Juno Pharmaceuticals, a specialty pharmaceutical company in Canada, for the commercialisation of its vertically integrated, complex formulation, Liraglutide, a drug-device combination for the treatment and management of Type 2 diabetes and obesity.

Diabetes 105

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

APRIL 10, 2023

India-based pharmaceutical company Cipla has entered into a perpetual licence agreement with Swiss drugmaker Novartis Pharma for the diabetes drug Galvus and its combination brands. Galvus brand products are mainly used in the treatment of patients with type 2 diabetes.

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

The Guardian - Pharmaceutical Industry

MAY 2, 2024

Novo Nordisk, which is now Europe’s most valuable company, also reports strong sales of diabetes drug Ozempic Strong sales of diabetes and weight loss drugs Ozempic and Wegovy have prompted the Danish pharmaceutical company Novo Nordisk to raise its 2024 profit forecast to up to £15.3bn, with supply shortages starting to ease.

Diabetes 70

Diabetes Pharmaceutical Companies Pharmaceutical Companies 70

Pharmafile

JANUARY 20, 2023

Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found in its popular type 2 diabetes drugs. The compound, known as nitrosamines or NTTP, often emerges from chemical reactions that can take place throughout the manufacturing process. read more

Compounding 52

Compounding Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

The Guardian - Pharmaceutical Industry

JUNE 25, 2024

Pharma group plans plant in North Carolina to produce diabetes drug and weight-loss product Wegovy Business live – latest updates Novo Nordisk is to invest more than $4bn (£3.2bn) in US manufacturing as it battles to keep up with booming demand for its obesity and diabetes drugs Wegovy and Ozempic.

Diabetes 77

Diabetes Pharmaceutical Companies Pharmaceutical Companies 77

Pharma Pathway

DECEMBER 5, 2022

Company Profile. Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression. Cipla- Openings for QC/ Production/ Engineering/ QA/ EHS/ Stores Dept.

Diabetes 92

Diabetes Pharmaceutical Companies Pharmaceutical Companies 92

Pharmafile

JANUARY 12, 2023

Clinical stage pharmaceutical company, Oramed Pharmaceuticals, has announced top-line results from its phase 3 randomised, double-blind, placebo-controlled, multicentre trial, which assessed the efficacy of ORMD-0801 compared to a placebo group. read more.

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

SEPTEMBER 12, 2024

The pharmaceutical industry is under pressure to ensure that vital health products are accessible to all, regardless of geographic location or socioeconomic status. The Foundation’s report highlights that 19 out of 20 companies assessed have approaches to track patient reach in LMICs, with AbbVie as the exception.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Diabetes 105

Express Pharma

JUNE 5, 2024

“The Company enjoys a leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS), and women’s health areas. Lupin is the third-largest pharmaceutical company in the U.S. by prescriptions.

Diabetes 96

Diabetes Pharmaceutical Companies Pharmaceutical Companies 96

The Guardian - Pharmaceutical Industry

NOVEMBER 2, 2023

Novo Nordisk says it struggling to keep up with demand after becoming Europe’s most valuable company Business live – latest updates The maker of blockbuster weight-loss drug semaglutide has reported a steep rise in sales and profits as health systems around the world rush to use it to tackle obesity. Continue reading.

Diabetes 84

Diabetes Pharmaceutical Companies Pharmaceutical Companies 84

Viseven

MARCH 27, 2023

In February 2019, Viseven, a global provider of digital solutions for the life sciences industry, announced a strategic collaboration with a global pharmaceutical company. This company specializes in biopharmaceuticals, diabetes care, obesity care, and other severe chronic diseases. Let us know!

Communication 52

Communication Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 8, 2022

Mark Doyle, co-founder of The Method and creator of the A Life in a Day programme, tells us about the immersive experience he and his team created that allows anyone to live the life of a type 2 diabetes patient for 24 hours. Therefore, Doyle and his team created The Life in a Day immersive experience for type 2 diabetes.

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

SEPTEMBER 17, 2022

Company Profile. Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression. Job Profile: . Female Medical Representatives.

Communication 88

Communication Diabetes Pharmaceutical Companies Pharmaceutical Companies 88

Pharma Marketing Network

NOVEMBER 24, 2024

Optimize your website to be mobile-friendly and create value-driven content around trending topics like “best treatment options for diabetes” to drive traffic. For instance, a diabetes educator discussing the benefits of Ozempic can create authenticity and trust in your brand. How can digital marketing benefit pharmaceutical companies?

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

MARCH 16, 2025

In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. Indian pharmaceutical companies have specialised in reverse-engineering complex medicines and producing biosimilars as alternatives to costly biologics.

Biosimilars 66

Biosimilars Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies 66

Pharma Pathway

NOVEMBER 26, 2022

Company Profile. Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression. Job Description. Organization: Cipla.

Diabetes 83

Diabetes Pharmaceutical Companies Pharmaceutical Companies 83

Pharma Marketing Network

MARCH 8, 2025

Introduction Pharmaceutical companies are investing heavily in digital advertising , and PPC campaign optimization is key to maximizing ROI while staying compliant. diabetes, cancer). So, how can pharma brands ensure their Google Ads, LinkedIn campaigns, and paid social media ads are effective?

HIPAA 59

HIPAA Pharmaceutical Companies Pharmaceutical Companies Labelling 59

Pharma Pathway

FEBRUARY 14, 2023

Chemistry On 26th Feb’ 2023 Company Profile Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression. Chemistry On 26th Feb’ 2023

Diabetes 86

Diabetes Pharmaceutical Companies Pharmaceutical Companies 86

The Guardian - Pharmaceutical Industry

AUGUST 29, 2023

Government claims prices could fall for 9m seniors but pharma companies claim cost-reduction program is unconstitutional The Biden administration has selected 10 drugs for the first round of price negotiations between Medicare and pharmaceutical companies in an effort to lower costs for seniors, it announced on Tuesday.

Diabetes 75

Diabetes Pharmaceutical Companies Pharmaceutical Companies 75

STAT

JULY 6, 2023

On one side is the Pharmaceutical Care Management Association, the trade association representing pharmacy benefit managers, which argues that pharmaceutical companies are responsible for high drug prices.

Drug Pricing 233

Drug Pricing Vaccines Diabetes Pharmaceutical Companies 233